title: Well-defined hydroxyethyl starch-10-hydroxy camptothecin super macromolecule conjugate: cytotoxicity, pharmacodynamics research, tissue distribution test and intravenous injection safety assessment.
abstract: 10-Hydroxy camptothecin (10-HCPT) is an antitumor agent effective in the treatment of several solid tumors but its use is hampered by poor water solubility, low lactone stability, short plasma half-life and dose-limiting toxicity. These limits of 10-HCPT had been overcome by our group through preparing super macromolecule prodrug: 10-HCPT-hydroxyethyl starch (HES) conjugate. In this study, we mainly evaluated in vitro and in vivo behavior of the prodrug, containing cytotoxicity assay, pharmacodynamics study, vascular irritation test, hemolysis experiment and tissue distribution test of rats. The irritation test results achieved much lower irritation than the commercial injection. The tissue distribution results showed that HES-10-HCPT conjugate increased significantly the 10-HCPT concentration in the tumor, liver and spleen site, whereas decreased the drug concentration in the heart and kidney. The hemolysis effect of the prepared conjugate was not obvious. The pharmacodynamics results indicated that HES-10-HCPT prodrug had a better antitumor efficiency against mice with H22 tumor than the commercial injection, and the inhibition ratio of tumor was 85.2% and 31.1%, respectively at the same dosage. These findings suggest that HES-10-HCPT prodrug is a promising drug delivery system providing improved good injection safety, greater tolerance and antitumor effect.
authors.affiliation: a Department of Pharmacy , Shengjing Hospital of China Medical University , Shenyang , China.
authors.forename: Guofei
authors.initials: G
authors.lastname: Li
authors.affiliation: a Department of Pharmacy , Shengjing Hospital of China Medical University , Shenyang , China.
authors.forename: Mingming
authors.initials: M
authors.lastname: Zhao
authors.affiliation: a Department of Pharmacy , Shengjing Hospital of China Medical University , Shenyang , China.
authors.forename: Limei
authors.initials: L
authors.lastname: Zhao
mesh_terms: D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000378:metabolism* / Q000494:pharmacology*; D002166:Camptothecin / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology*; D045744:Cell Line, Tumor; D016503:Drug Delivery Systems / Q000379:methods; D006168:Guinea Pigs; D006207:Half-Life; D006461:Hemolysis / Q000187:drug effects; D006895:Hydroxyethyl Starch Derivatives / Q000737:chemistry* / Q000378:metabolism*; D007275:Injections, Intravenous / Q000379:methods; D007783:Lactones / Q000737:chemistry; D008297:Male; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D011355:Prodrugs / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012995:Solubility; D014018:Tissue Distribution / Q000502:physiology
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D006895:Hydroxyethyl Starch Derivatives; D007783:Lactones; D011355:Prodrugs; D002166:Camptothecin
keywords: 10-Hydroxy camptothecin; hydroxyethyl starch; intravenous safety; macromolecule prodrug; pharmacodynamics; tissue distribution